Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
03/2000
03/26/2000CA2283350A1 Method of preparing pharmaceutical artemisia extract and apparatus for electrical moxibustion using the extract
03/23/2000WO2000016231A1 Method for screening and producing compound libraries
03/23/2000WO2000015262A1 Dry powder active agent pulmonary delivery
03/23/2000WO2000015179A2 Cosmetic composition
03/23/2000WO2000015178A2 Computer implemented pharmacokinetics method and program
03/23/2000WO2000003686A3 Acne treatment compositions
03/23/2000WO1999046316A3 Enzyme inhibitors
03/23/2000CA2344036A1 Pharmacokinetic-based drug design tool and method
03/23/2000CA2343920A1 Aerosolizable particles resistant to hygroscopic growth
03/23/2000CA2343914A1 Method for screening and producing compound libraries
03/23/2000CA2341767A1 Promotion or inhibition of angiogenesis and cardiovascularization
03/22/2000EP0987269A1 Salts of optically active sulfoxide derivative
03/22/2000EP0986580A1 Oligosaccharide mixtures having antithrombotic activity
03/22/2000EP0986371A1 Liquid antimicrobial cleansing compositions
03/22/2000EP0986365A1 Striped dentifrice stable to color bleeding
03/22/2000EP0986363A2 Leave-on antimicrobial compositions
03/22/2000CN1248168A Use of 9,10-secocholesta-5,7,10 (19)-triene-1,3-diol, or alfacacidol
03/21/2000US6039951 Applying a mixture of chili pepper extract with lubricants, oils, creams
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000013671A1 Immediate release tablet
03/16/2000WO2000013664A1 Drug preparations for treating sexual dysfunction
03/16/2000DE19930769A1 Verfahren zur dauerhaften Verformung keratinischer Fasern und Mittel Process for the permanent deformation of keratin fibers and means
03/16/2000CA2342769A1 Drug preparations for treating sexual dysfunction
03/15/2000EP0985415A1 Uracil reductase inactivators
03/15/2000EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
03/15/2000EP0984957A1 NOVEL FORM OF $i(S)OMEPRAZOLE
03/15/2000EP0984785A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
03/15/2000EP0984770A1 Mild, rinse-off antimicrobial liquid cleansing compositions containing acidic surfactants
03/15/2000EP0550580B1 Uracil reductase inactivator
03/15/2000CN1247466A Antiperspirant or deodorant compsns.
03/15/2000CN1247465A Antiperspirant or deodorant compsns.
03/15/2000CN1050302C Chicken anaemia agent vaccine
03/15/2000CN1050285C Method for prepn. of pressurised aerosol compositions
03/14/2000US6037363 Respiratory system disorders, cystic fibrosis
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6036964 Cosmetics with multicomponent base and fragrance
03/09/2000WO2000012484A1 Tan-1057 derivatives
03/09/2000WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
03/09/2000WO2000012069A1 Therapeutic formulation for administering tolterodine with controlled release
03/09/2000WO2000012057A1 Dyeing composition for keratinous fibres with a cationic direct colouring agent and a silicone
03/09/2000WO2000012045A2 Method for treating neurodegenerative disorders
03/09/2000WO1999058123A3 Novel fatty acid analogues for the treatment of primary and secondary restenosis
03/09/2000DE19838998A1 Neue Naturstoffderivate New natural product derivatives
03/08/2000EP0984013A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane
03/08/2000EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
03/08/2000EP0983361A1 Bacterial pheromones and uses therefor
03/08/2000EP0983041A1 Aqueous carrier systems for water-insoluble materials
03/08/2000EP0755222A4 Microfluidization of calcium/oxyanion-containing particles
03/08/2000CN1246800A Infectious bursits vaccine
03/08/2000CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
03/08/2000CN1246331A Hair dye composite for keratin fibre containing cation direction dye and polymer thickening agent
03/08/2000CN1246330A Keratin fibre hair dye composite containing cation direction dye and polymer thickening agent
03/07/2000US6034070 Veterinary medicine
03/07/2000US6033649 Light screening agents
03/02/2000WO2000011001A1 Muscarinic agonists and antagonists
03/02/2000WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors
03/02/2000WO2000010526A2 New oral formulation for 5-ht4 agonists or antagonists
03/02/2000WO2000010519A1 Dyeing composition for keratinous fibres with direct cationic colouring agent and a non-ionic surfactant
03/02/2000WO2000010518A1 Dyeing composition for keratinous fibres with a direct cationic colouring agent and a surfactant
03/02/2000WO2000010517A1 Dyeing composition for keratinous fibres with direct cationic colouring agent and a quaternary ammonium salt
03/02/2000CA2340946A1 Muscarinic agonists and antagonists
03/02/2000CA2306408A1 Dyeing composition for keratinous fibres with a direct cationic colouring agent and a surfactant
03/02/2000CA2305498A1 Dyeing composition for keratinous fibres with direct cationic colouring agent and a non-ionic surfactant
03/01/2000EP0981527A1 Salt of naphthyridine carboxylic acid derivative
03/01/2000EP0981350A1 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol
03/01/2000EP0981326A1 Personal cleansing compositions
03/01/2000EP0981323A1 Desensitizing dentifrice having limited astringency
03/01/2000CN1246049A Hair coloring compositions
03/01/2000CN1246048A Hair coloring compositions
03/01/2000CN1246047A Hair coloring compositions
03/01/2000CN1246046A Hair coloring compositions
02/2000
02/29/2000US6030962 Vitamin D3 analogs with bis C-20 side chains
02/29/2000US6030622 Herbal extract composition and method with immune-boosting capability
02/29/2000US6030604 Formulation for inhalation
02/24/2000WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/24/2000WO2000009149A1 Tnf-derived peptides for use in treating oedema
02/24/2000WO2000009141A1 Method and pharmaceutical composition for reducing serum homocysteine concentration
02/24/2000CA2339304A1 Composition and method of using tumor cells
02/23/2000EP0980354A2 Vitamin d 3? analogs with bis c-20 side chains
02/23/2000EP0980250A1 Plant extracts for the treatment of increase bone resorption
02/23/2000EP0980239A1 Cosmetic skin conditioning compositions
02/23/2000CN1245413A Hair coloring compositions
02/23/2000CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B
02/17/2000WO2000007987A1 Crystalline forms of osanetant
02/17/2000WO2000007581A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
02/17/2000WO2000001815A3 Neurotrophic factors
02/17/2000CA2339007A1 Crystalline forms of osanetant
02/17/2000CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
02/16/2000EP0979827A1 Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same
02/16/2000EP0979083A2 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
02/16/2000CN1244790A Aerosol device based on alcoholic compositions of binding materials containing anionic grafted silicon polymers
02/16/2000CN1244785A Foaming personal cleansing product
02/16/2000CN1244528A Di- Or triaza-spiral [4,5] decane derivative
02/15/2000US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
02/15/2000US6024982 Immediate release tablet cores of insoluble drugs having sustained-release coating
02/15/2000US6024978 Oral drug composition with lipophilic compounds
02/15/2000US6024963 Potentiation of immunogenic response
02/15/2000US6024769 Process for dyeing keratinous fibres with an alkoxymetaphenylenediamine at acidic pH and compositions used
02/09/2000EP0977774A1 Antipathogenic synthetic peptides and compositions comprising them
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 295